Sochor H
Department of Cardiology, University of Vienna, Austria.
Am J Cardiol. 1990 Oct 16;66(13):91E-96E. doi: 10.1016/0002-9149(90)90619-c.
Since the introduction of technetium-99m methoxy-isobutyl isonitrile (Tc-99m sestamibi) in Europe, there has been a growing interest in its use. Several European multicenter trials have been conducted to evaluate this new agent in relation to the traditional perfusion marker thallium-201, and other studies are in progress to understand the use of this perfusion marker for the diagnosis of coronary disease, for use in conjunction with pharmacologic vasodilation, for use in the assessment of ventricular function and wall motion and for the assessment of interventions.
自从锝-99m甲氧基异丁基异腈（Tc-99m司他比）在欧洲引入以来，人们对其使用的兴趣与日俱增。已经开展了多项欧洲多中心试验，以评估这种新型试剂与传统灌注标记物铊-201相比的情况，并且正在进行其他研究，以了解这种灌注标记物在冠心病诊断中的应用、与药物性血管扩张联合使用的情况、在心室功能和室壁运动评估中的应用以及在干预措施评估中的应用。
